Skip to content

Bio -X Diagnostics

Active
Public limited companyfounded 199036 yrs activeRue de la Calestienne 38, 5580 Rochefort, BelgiumKBO/BCE: BE 0441.580.721
Summary

Bio -X Diagnostics has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.6m and a net result of €56,097. Equity remains stable across the filed fiscal years (±0.9% per year). Its solvency ranks better than 76% of 5113 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability61▼-5
Solvency95▲+2
Growth37=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €260,000 at 30 days acceptable
Liquidity ample (current ratio 1.65 against 1.89 in 2024; short-term debt: 29.1% and cash: 2.6% of total assets), and 29.7% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 36 years 0 40 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
70.3%
Return on assets
1.1%
Age of the figures
13 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-08-2025 was due by 31-03-2026 and was filed on 30-03-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 d early
2024
24 d late
2023
10 d early
2022
8 d early
2021
10 d early
2020
on the day
2019
16 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 3 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-08-2026 and is due by 31-03-2027. Nothing is late today. Usually files around 23 March (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
31-08-2026 close01-10-2026 today31-03-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 23 April 1990, Bio -X Diagnostics was incorporated.1 Revenue went from EUR 5.1 million in 2020 to EUR 6.1 million in 2025 and headcount from 22.5 full-time equivalents in 2019 to 24.6 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2019, 2020 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€6.1m▲ 3.1%
2024 · €5.9m
EBIT margin
0.8%▼ 2.4pp
2024 · 3.2%
Net result
€56,097▼ 67.9%
2024 · €174,667
Working capital
€979,087▼ 20.9%
2024 · €1.2m
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover€6.5m▲ 28.3%€6.0m▼ 7.3%€6.0m▲ 0.1%€5.9m▼ 2.3%€6.1m▲ 3.1%
Operating result€631,536▲ 316%€182,879▼ 71.0%€115,093▼ 37.1%€189,944▲ 65.0%€47,515▼ 75.0%
Net result€1.2mabove the sector's middle half▲ 4,967%€754,253above the sector's middle half▼ 38.9%€112,180within the sector's middle half▼ 85.1%€174,667within the sector's middle half▲ 55.7%€56,097within the sector's middle half▼ 67.9%
EBIT margin9.7%▲ 6.7pp3.0%▼ 6.7pp1.9%▼ 1.1pp3.2%▲ 1.3pp0.8%▼ 2.4pp
Equity€2.8mwithin the sector's middle half▼ 25.6%€3.4mwithin the sector's middle half▲ 21.4%€3.5mwithin the sector's middle half▲ 1.3%€3.6mwithin the sector's middle half▲ 3.9%€3.6mwithin the sector's middle half▲ 0.5%
Total assets€5.6mwithin the sector's middle half▲ 1.4%€5.5mwithin the sector's middle half▼ 1.5%€5.3mwithin the sector's middle half▼ 4.6%€5.3mwithin the sector's middle half▲ 0.9%€5.2mwithin the sector's middle half▼ 2.9%
Debt€2.8m▲ 60.1%€2.1m▼ 24.9%€1.8m▼ 14.4%€1.7m▼ 5.0%€1.5m▼ 9.9%
Working capital€518,441within the sector's middle half▼ 66.4%€1.1mwithin the sector's middle half▲ 106%€1.1mwithin the sector's middle half▲ 1.0%€1.2mwithin the sector's middle half▲ 14.6%€979,087within the sector's middle half▼ 20.9%
Solvency50.4%within the sector's middle half▼ 18.2pp62.1%above the sector's middle half▲ 11.8pp66.0%above the sector's middle half▲ 3.9pp67.9%above the sector's middle half▲ 1.9pp70.3%above the sector's middle half▲ 2.4pp
Current ratio1.25within the sector's middle half▼ 1.551.69within the sector's middle half▲ 0.441.77within the sector's middle half▲ 0.081.89within the sector's middle half▲ 0.131.65within the sector's middle half▼ 0.24
Return on assets (ROA)21.9%above the sector's middle half▲ 21.5pp13.6%above the sector's middle half▼ 8.3pp2.1%within the sector's middle half▼ 11.5pp3.3%within the sector's middle half▲ 1.2pp1.1%within the sector's middle half▼ 2.2pp
Staff (FTE)20.4within the sector's middle half▼ 5.6%24.9within the sector's middle half▲ 22.1%24.5within the sector's middle half▼ 1.6%23.9within the sector's middle half▼ 2.4%24.6within the sector's middle half▲ 2.9%
above within below the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Why a figure moved sharply
  • 2021 Net result +4,967% on 2020. The previous fiscal year ran 14 months, this one 12.
Result per fiscal year
Operating resultNet result
€0€500,000€1.0mOperating result 2021: €631,536€631,536Net result 2021: €1.2m€1.2mOperating result 2022: €182,879€182,879Net result 2022: €754,253€754,253Operating result 2023: €115,093€115,093Net result 2023: €112,180Operating result 2024: €189,944€189,944Net result 2024: €174,667€174,667Operating result 2025: €47,515€47,515Net result 2025: €56,097€56,09720212022202320242025€0€50,000€100,000€150,000€200,000Operating result 2023: €115,093€115,000Net result 2023: €112,180€112,000Operating result 2024: €189,944€190,000Net result 2024: €174,667€175,000Operating result 2025: €47,515€47,500Net result 2025: €56,097€56,100202320242025
The operating result falls in 2025; 2025 is 75% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €5.2m
Fixed assets €2.7m ▼ 0.7%
Current assets €2.5m ▼ 5.2%
Equity and liabilities €5.2m
Equity €3.6m ▲ 0.5%
Provisions €0 ▼ 100%
Debt €1.5m ▼ 9.9%
Debt's share of the balance-sheet total falls from 32.0% to 29.7%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€353,806▼
2024 · €475,037
Cash flow
€362,388▼
2024 · €459,759
Quick ratio
0.53▼
2024 · 0.85
Debt to equity
0.42▼
2024 · 0.47
ROE
1.5%▼
2024 · 4.8%
Interest coverage
54.67▲
2024 · 52.85
Debt ≤ 1 year
€1.5m▲
2024 · €1.4m
Debt > 1 year
€29,513▼
2024 · €205,258
Income taxes
€8,447▼
2024 · €35,098
Staff costs
€1.7m▲
2024 · €1.4m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 14,732 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 96% are still going.

  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet
0.2% went bankrupt
3.5% stopped otherwise
96% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.3% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 14,732 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 84 lines
Balance sheet Code20242025
Assets
Total assets20/58€5.3m€5.2m▼
Fixed assets21/28€2.7m€2.7m▼
Intangible fixed assets21€138,130€159,057▲
Tangible fixed assets22/27€1.4m€1.4m▼
Land and buildings22€1.1m€969,253▼
Plant, machinery and equipment23€73,330€95,290▲
Furniture and vehicles24€251,711€311,588▲
Other tangible fixed assets26€15,904€8,785▼
Financial fixed assets28€1.2m€1.2m=
Affiliated companies280/1€1.2m€1.2m=
Participating interests280€1.2m€1.2m=
Other financial fixed assets284/8€50€50=
Amounts receivable and cash guarantees285/8€50€50=
Current assets29/58€2.6m€2.5m▼
Stocks and contracts in progress3€1.4m€1.7m▲
Stocks30/36€1.4m€1.7m▲
Finished goods33€793,845€815,103▲
Goods purchased for resale34€646,813€866,746▲
Amounts receivable within one year40/41€691,762€625,880▼
Trade receivables40€602,612€512,503▼
Other amounts receivable41€89,151€113,377▲
Cash at bank and in hand54/58€432,349€136,803▼
Deferred charges and accrued income490/1€60,378€44,318▼
Equity and liabilities
Total equity and liabilities10/49€5.3m€5.2m▼
Equity10/15€3.6m€3.6m▲
Contributions10/11€2.1m€2.1m=
Capital10€2.1m€2.1m=
Issued capital100€2.1m€2.1m=
Reserves13€165,617€168,422▲
Non-distributable reserves130/1€165,617€168,422▲
Legal reserve130€165,617€168,422▲
Profit (loss) carried forward14€1.1m€1.1m▲
Investment grants15€277,044€238,156▼
Provisions and deferred taxes16€4,439-
Provisions for liabilities and charges160/5€4,439-
Other liabilities and charges164/5€4,439-
Amounts payable17/49€1.7m€1.5m▼
Amounts payable after more than one year17€205,258€29,513▼
Financial debts170/4€205,258€29,513▼
Credit institutions173€205,258€29,513▼
Amounts payable within one year42/48€1.4m€1.5m▲
Current portion of amounts payable after more than one year42€173,486€175,746▲
Trade debts44€964,472€1.1m▲
Suppliers440/4€964,472€1.1m▲
Taxes, remuneration and social security45€235,262€214,863▼
Taxes450/3€14,718€26,622▲
Remuneration and social security454/9€220,543€188,240▼
Other amounts payable47/48€14,858€11,550▼
Accrued charges and deferred income492/3€114,696-
Income statement Code20242025
Operating income70/76A€6.3m€6.4m▲
Turnover70€5.9m€6.1m▲
Change in stocks of work in progress, finished goods and contracts in progress71€158,755€21,258▼
Other operating income74€217,493€334,648▲
Non-recurring operating income76A€1,000-
Operating charges60/66A€6.1m€6.4m▲
Goods for resale, raw materials and consumables60€3.5m€3.4m▼
Purchases600/8€3.3m€3.6m▲
Change in stocks: decrease (increase)609€138,500-€219,933▼
Services and other goods61€866,480€960,472▲
Remuneration, social security and pensions62€1.4m€1.7m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€285,093€306,291▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€801-
Provisions for liabilities and charges: additions (uses and reversals)635/8€4,439-€4,439▼
Other operating charges640/8€54,944€66,115▲
Non-recurring operating charges66A-€4,439
Operating profit (loss)9901€189,944€47,515▼
Financial income75/76B€43,338€39,334▼
Recurring financial income75€43,338€39,334▼
Other financial income752/9€43,338€39,334▼
Financial charges65/66B€23,518€22,306▼
Recurring financial charges65€23,518€22,306▼
Debt charges650€8,988€6,472▼
Other financial charges652/9€14,531€15,834▲
Profit (loss) for the period before taxes9903€209,764€64,543▼
Income taxes67/77€35,098€8,447▼
Taxes670/3€35,098€25,000▼
Tax adjustments and reversals of tax provisions77-€16,553
Profit (loss) for the period9904€174,667€56,097▼
Profit (loss) for the period to be appropriated9905€174,667€56,097▼
Appropriation of the result
Profit (loss) to be appropriated9906€1.1m€1.1m▲
Profit (loss) brought forward from the previous period14P€899,194€1.1m▲
Transfer to equity691/2€8,733€2,805▼
To the legal reserve6920€8,733€2,805▼
Social balance
Average headcount (FTE)908723.924.6▲

The notes to these accounts (61 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Operating income70/76A-€6.4m€6.4m€6.3m€6.4m▲ 2.6%
Turnover70€6.5m€6.0m€6.0m€5.9m€6.1m▲ 3.1%
Change in stocks of work in progress, finished goods and contracts in progress71-€118,132€112,995€158,755€21,258▼ 86.6%
Other operating income74-€220,501€275,929€217,493€334,648▲ 53.9%
Non-recurring operating income76A-€3,068-€1,000--
Operating charges60/66A-€6.2m€6.3m€6.1m€6.4m▲ 5.0%
Goods for resale, raw materials and consumables60-€3.6m€3.4m€3.5m€3.4m▼ 1.8%
Purchases600/8-€3.8m€3.4m€3.3m€3.6m▲ 9.0%
Change in stocks: decrease (increase)609--€193,307€27,069€138,500-€219,933▼ 259%
Services and other goods61-€952,190€1.1m€866,480€960,472▲ 10.8%
Remuneration, social security and pensions62-€1.3m€1.5m€1.4m€1.7m▲ 17.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€329,521€289,492€300,257€285,093€306,291▲ 7.4%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4--€2,970€515€801--
Provisions for liabilities and charges: additions (uses and reversals)635/8---€4,439-€4,439▼ 200%
Other operating charges640/8-€35,935€45,309€54,944€66,115▲ 20.3%
Non-recurring operating charges66A--€9,549-€4,439-
Operating profit (loss)9901€631,536€182,879€115,093€189,944€47,515▼ 75.0%
Financial income75/76B-€641,979€42,057€43,338€39,334▼ 9.2%
Recurring financial income75€753,097€641,979€42,057€43,338€39,334▼ 9.2%
Income from financial fixed assets750-€600,167----
Income from current assets751-€1,096€1,302---
Other financial income752/9-€40,716€40,755€43,338€39,334▼ 9.2%
Financial charges65/66B-€17,537€21,028€23,518€22,306▼ 5.2%
Recurring financial charges65€21,699€17,537€21,028€23,518€22,306▼ 5.2%
Debt charges650€13,734€10,598€9,828€8,988€6,472▼ 28.0%
Other financial charges652/9-€6,939€11,201€14,531€15,834▲ 9.0%
Profit (loss) for the period before taxes9903€1.4m€807,321€136,121€209,764€64,543▼ 69.2%
Income taxes67/77€128,651€53,068€23,941€35,098€8,447▼ 75.9%
Taxes670/3-€57,000€23,941€35,098€25,000▼ 28.8%
Tax adjustments and reversals of tax provisions77-€3,932--€16,553-
Profit (loss) for the period9904€1.2m€754,253€112,180€174,667€56,097▼ 67.9%
Transfer from tax-exempt reserves789-€11,500----
Profit (loss) for the period to be appropriated9905€1.2m€765,753€112,180€174,667€56,097▼ 67.9%
Line20212022202320242025Change
Assets
Total assets20/58€5.6m€5.5m€5.3m€5.3m€5.2m▼ 2.9%
Fixed assets21/28€3.0m€2.9m€2.8m€2.7m€2.7m▼ 0.7%
Intangible fixed assets21€179,058€152,429€125,322€138,130€159,057▲ 15.1%
Tangible fixed assets22/27€1.7m€1.6m€1.5m€1.4m€1.4m▼ 2.8%
Land and buildings22-€1.3m€1.2m€1.1m€969,253▼ 10.6%
Plant, machinery and equipment23-€78,229€85,185€73,330€95,290▲ 29.9%
Furniture and vehicles24-€204,137€212,957€251,711€311,588▲ 23.8%
Other tangible fixed assets26-€31,399€23,652€15,904€8,785▼ 44.8%
Financial fixed assets28€1.2m€1.2m€1.2m€1.2m€1.2m=
Affiliated companies280/1-€1.2m€1.2m€1.2m€1.2m=
Participating interests280-€1.2m€1.2m€1.2m€1.2m=
Other financial fixed assets284/8-€50€50€50€50=
Amounts receivable and cash guarantees285/8-€50€50€50€50=
Current assets29/58€2.6m€2.6m€2.5m€2.6m€2.5m▼ 5.2%
Stocks and contracts in progress3€1.0m€1.3m€1.4m€1.4m€1.7m▲ 16.7%
Stocks30/36-€1.3m€1.4m€1.4m€1.7m▲ 16.7%
Finished goods33-€522,095€635,090€793,845€815,103▲ 2.7%
Goods purchased for resale34-€812,382€785,313€646,813€866,746▲ 34.0%
Amounts receivable within one year40/41€541,540€851,111€513,890€691,762€625,880▼ 9.5%
Trade receivables40-€560,057€403,685€602,612€512,503▼ 15.0%
Other amounts receivable41-€291,054€110,205€89,151€113,377▲ 27.2%
Cash at bank and in hand54/58€973,121€346,931€515,734€432,349€136,803▼ 68.4%
Deferred charges and accrued income490/1-€85,992€39,728€60,378€44,318▼ 26.6%
Equity and liabilities
Total equity and liabilities10/49€5.6m€5.5m€5.3m€5.3m€5.2m▼ 2.9%
Equity10/15€2.8m€3.4m€3.5m€3.6m€3.6m▲ 0.5%
Contributions10/11€2.1m€2.1m€2.1m€2.1m€2.1m=
Capital10-€2.1m€2.1m€2.1m€2.1m=
Issued capital100-€2.1m€2.1m€2.1m€2.1m=
Reserves13€124,487€151,274€156,883€165,617€168,422▲ 1.7%
Non-distributable reserves130/1-€151,274€156,883€165,617€168,422▲ 1.7%
Legal reserve130-€151,274€156,883€165,617€168,422▲ 1.7%
Profit (loss) carried forward14€198,954€820,715€899,194€1.1m€1.1m▲ 5.0%
Investment grants15-€355,996€316,761€277,044€238,156▼ 14.0%
Provisions and deferred taxes16---€4,439--
Provisions for liabilities and charges160/5---€4,439--
Other liabilities and charges164/5---€4,439--
Amounts payable17/49€2.8m€2.1m€1.8m€1.7m€1.5m▼ 9.9%
Amounts payable after more than one year17€719,053€550,000€378,744€205,258€29,513▼ 85.6%
Financial debts170/4-€550,000€378,744€205,258€29,513▼ 85.6%
Credit institutions173-€550,000€378,744€205,258€29,513▼ 85.6%
Amounts payable within one year42/48€2.1m€1.6m€1.4m€1.4m€1.5m▲ 8.8%
Current portion of amounts payable after more than one year42-€205,249€230,606€173,486€175,746▲ 1.3%
Trade debts44€725,144€1.0m€849,283€964,472€1.1m▲ 14.8%
Suppliers440/4-€1.0m€849,283€964,472€1.1m▲ 14.8%
Taxes, remuneration and social security45-€218,137€241,402€235,262€214,863▼ 8.7%
Taxes450/3-€8€1,149€14,718€26,622▲ 80.9%
Remuneration and social security454/9-€218,129€240,253€220,543€188,240▼ 14.6%
Other amounts payable47/48-€114,860€89,309€14,858€11,550▼ 22.3%
Accrued charges and deferred income492/3-€50€9,365€114,696--
Line20212022202320242025Change
Profit (loss) for the period9904€1.2m€754,253€112,180€174,667€56,097▼ 67.9%
+ Depreciation and write-downs630€329,521€289,492€300,257€285,093€306,291▲ 7.4%
Operating cash flow (approximation)€1.6m€1.0m€412,437€459,759€362,388▼ 21.2%
Investment in fixed assets (approximation)--€179,427-€172,113-€198,411-€286,603▼ 44.4%
Change in cash--€626,190€168,803-€83,385-€295,546▼ 254%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-03-2027
2026
30-03
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
24-04
NBB filing Annual accounts filed
fiscal year 2024 · full schema · 24 days late
2024
21-03
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
23-03
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
21-03
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
31-08
Financial Highest result since 2019net €1.2m ▲4,967%
Operating result €631,536, net result €1.2m, both a record.
31-03
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
31-08
Financial Weakest financial yearnet €24,361 ▼92%
Net result drops to €24,361, the lowest in the series; recovery starts the following year.
15-01
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
11-01
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
11-01
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
13-01
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts

We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 6 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Rochefort · 1 establishment unit since 1990
seat establishment The establishment unit on the map
Ground area
4,905 m²
Building footprint
509 m²
Parcel 91114D0003/00Z002, Wallonia. Linked by address, not a title deed.
1 establishment unit
Bio-X Diagnostics
Rue de la Calestienne 38, 5580 RochefortNACE 2466010
since 19902.052.450.813
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
91114D0003/00Z002 Wallonia 4,905 m² 1 · 509 m² -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 owner · 1 holding

Chain of control

  1. HOLDING MAESTRO 51.02%
  2. Bio -X Diagnostics

Highest known parent: HOLDING MAESTRO. The sources do not say who stands above it.

Owners 1

Holdings 1

According to the annual accounts to 31-08-2025 of Bio -X Diagnostics and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 1,228 companies in this sector we hold annual accounts for 528. 326 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPublic limited company
Founded23-04-1990
Fiscal year end31-08
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
46851Wholesale of industrial chemicals
E-invoicing
Reachable via Peppol
Peppol ID 0208:0441580721
Registered 06-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.